Current population · 2,231
A Neutralizing Monoclonal Antibody for Hospitalized Patients with Covid-19.
ACTIV-3/TICO LY-CoV555 Study Group; Lundgren JD, Grund B, Barkauskas CE, Holl...
← ExplorerSource ↗Publication identity
Publication IDCPD-1627
Year2021
PMID33356051
DOI10.1056/NEJMoa2033130
JournalNot recorded
AuthorsACTIV-3/TICO LY-CoV555 Study Group; Lundgren JD, Grund B, Barkauskas CE, Holl...
First authorACTIV-3/TICO LY-CoV555 Study Group; Lundgren JD
Senior authorNeaton JD.N Engl J Med.
Scientific classification
Research themeCOVID-19 / respiratory viruses
Pathogen groupSARS-CoV-2
Technology / methodSerology / immunology; Clinical trial / therapy
Object stateOBSERVED
Provenance & boundary
Generated Passport: this is a derived view of the canonical publication object. Missing or unsupported information remains unfilled; no scientific interpretation or current-staff status is manufactured.
PopulationCIDM Publications · 2,231
Source statussource-derived / affiliation verification required
Investigator sourceMatthew Watts,
Canonical source URLhttps://pubmed.ncbi.nlm.nih.gov/33356051/
Author / Colleague Reality Return
Return corrections about identity, authorship, paper-specific CIDM/CIDM-PH affiliation, metadata, source/provenance, figure/table linkage, evidence boundary, or links.
Feedback → source check → evidence status → warranted correction → versioned update.
Open feedback route →